Doximity Reports Q3 FY26 Results, Authorizes $500M Stock Repurchase, and Announces CFO Medical Leave

summarizeSummary

Doximity announced Q3 FY26 results with mixed financial metrics, a significant $500 million stock repurchase program, and a temporary medical leave for its CFO with an internal interim replacement.

check_boxKey Events

• Q3 FY26 Financial Results Announced

  Doximity reported Q3 FY26 revenue of $185.1 million (up 10% Y/Y), net income of $61.6 million (down from $75.2M Y/Y), and Adjusted EBITDA of $111.4 million (up 9% Y/Y). Diluted EPS was $0.31 (down from $0.37 Y/Y), while non-GAAP diluted EPS was $0.46 (up from $0.45 Y/Y).

• New $500 Million Stock Repurchase Program Authorized

  The Board of Directors authorized a new program to repurchase up to $500 million of Class A common stock. This substantial capital return initiative comes as the stock trades below its 52-week low, indicating management's confidence in the company's valuation.

• CFO Takes Temporary Medical Leave

  Anna Bryson, the company's Chief Financial Officer, is taking a temporary medical leave of absence. Siddharth Sitaram, Chief Accounting Officer, has been appointed interim principal financial and accounting officer, leveraging his internal experience.

• Updated Fiscal Year 2026 Guidance

  The company updated its fiscal year 2026 guidance, projecting revenue between $642.5 million and $643.5 million, and Adjusted EBITDA between $355.5 million and $356.5 million.

auto_awesomeAnalysis

Doximity's latest 8-K filing presents a mixed financial picture alongside a significant capital allocation decision and a temporary executive change. While GAAP net income and diluted EPS saw year-over-year declines, the company reported a 10% increase in revenue and a 9% rise in Adjusted EBITDA, with non-GAAP diluted EPS slightly increasing. The most impactful announcement is the authorization of a new $500 million stock repurchase program, which represents a substantial portion of the company's market capitalization. This move is particularly noteworthy as the stock is currently trading below its 52-week low, signaling strong management confidence in the company's valuation and a commitment to shareholder returns. Additionally, the CFO is taking a temporary medical leave, with an experienced internal Chief Accounting Officer stepping in as interim, which helps mitigate potential disruption.